• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Networks

Clinical Research and Clinical Trials

International network of researchers who are exploring ways to prevent, delay and reverse the progression of type 1 diabetes.
International clinical research consortium dedicated to the clinical evaluation of novel tolerogenic approaches for the treatment of autoimmune diseases, asthma and allergic diseases, and the prevention of graft rejection.
International consortium of six centers assembled to participate in the development and implementation of studies to identify infectious agents, dietary factors, or other environmental agents, including psychosocial factors, that trigger type 1 diabetes in genetically susceptible people
Network of clinical centers and a data coordinating center established to conduct studies of islet transplantation in patients with type 1 diabetes.
All Clinical Islet Transplantation (CIT) Consortium data and supporting documents have been posted online in two places: http://www.immport.org/  (supported by NIAID) and https://repository.niddk.nih.gov/  (supported by NIDDK)

Pathology, Islet Resources, Animal Models

The Human Pancreas Analysis Program (HPAP) is performing deep phenotyping of the human endocrine pancreas and its interaction with the immune system, to better understand the cellular and molecular events that precede and lead to beta-cell loss in Type-1 Diabetes (T1D) and islet dysfunction in Type-2 Diabetes (T2D). The National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) supports HPAP through multiple NIH grants.
The goal of the Integrated Islet Distribution Program (IIDP) is to work with the leading islet isolation centers in the U.S. to distribute high quality human islets to the diabetes research community, in order to advance scientific discoveries and translational medicine.
Network helps to organize and support collaborative research related to loss of functional beta cell mass in Type 1 Diabetes (T1D).
A collaborative research project that supports nPOD approved diabetes investigators by freely providing rare and difficult-to-obtain tissues from type 1 and type 2 diabetes donors.

Powered by

About

Understanding Type 1 Diabetes Research Networks

Recent News Entries

Contact Us

About SciCrunch | Privacy Policy | Terms of Service

SciCrunch
X

Are you sure you want to delete that component?